The following license files are associated with this item:
- QMRO Home
- William Harvey Research Institute
- Centre for Experimental Medicine and Rheumatology (EMR)
- Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
Browse
Administrators only